Lv5
1470 积分 2024-01-24 加入
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer
2天前
已完结
Lactylation in cancer progression and drug resistance
2天前
已完结
Enhancing immunotherapy with tumour-responsive nanomaterials
2天前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
2天前
已完结
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
2天前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
2天前
已完结
Phosphoinositide kinases in cancer: from molecular mechanisms to therapeutic opportunities
2天前
已完结
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
2天前
已完结
Evolutionary paths towards metastasis
2天前
已完结
Targeted protein degradation for cancer therapy
2天前
已完结
皖公网安备34019202002308
